The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries
Open accessAbstract
Background: Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities of hypertension prevalence, awareness, treatment, and control in 2010 and compared secular changes from 2000 to 2010. Methods: We searched MEDLINE from 1995 through 2014 and supplemented with manual searches of retrieved article references. We included 135 population-based studies of 968 419 adults from 90 countries. Sex- and age-specific hypertension prevalences from each country were applied to population data to calculate regional and global numbers of hypertensive adults. Proportions of awareness, treatment, and control from each country were applied to hypertensive populations to obtain regional and global estimates. Results: In 2010, 31.1% (95% confidence interval, 30.0%–32.2%) of the world’s adults had hypertension; 28.5% (27.3%–29.7%) in high-income countries and 31.5% (30.2%–32.9%) in low- and middle-income countries. An estimated 1.39 (1.34–1.44) billion people had hypertension in 2010: 349 (337–361) million in high-income countries and 1.04 (0.99–1.09) billion in low- and middle-income countries. From 2000 to 2010, the age-standardized prevalence of hypertension decreased by 2.6% in high-income countries, but increased by 7.7% in low- and middle-income countries. During the same period, the proportions of awareness (58.2% versus 67.0%), treatment (44.5% versus 55.6%), and control (17.9% versus 28.4%) increased substantially in high-income countries, whereas awareness (32.3% versus 37.9%) and treatment (24.9% versus 29.0%) increased less, and control (8.4% versus 7.7%) even slightly decreased in low- and middle-income countries. Conclusions: Global hypertension disparities are large and increasing. Collaborative efforts are urgently needed to combat the emerging hypertension burden in low- and middle-income countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Despite several initiatives, the prevalence of raised BP and adverse impact on cardiovascular morbidity and mortality are increasing globally, irrespective of income. 4,5”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When reviewing global figures, an estimated 1.39 billion people had hypertension in 2010. 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The large disparities in the regional burden of hypertension are accompanied by low levels of awareness, treatment and control rates in LMIC, when compared to HIC.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“with an estimated 349 million with hypertension in HIC and 1.04 billion in LMICs. 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“In response to poor global awareness for hypertension (estimated 67% in HIC and 38% in LMIC), 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“good BP control was only achieved in less than one-third and one-tenth of patients with hypertension in highincome and lower-income countries, respectively. 4”
In the citing paper
“About 1/4th of adults have high blood pressure”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Between 1.13 and 1.4 billion people had hypertension in 2010 (defined as >140/90 mm Hg.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Worldwide, about half of adults with hypertension are unaware that their blood pressure is high, a situation more dire in low-income countries.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Two-thirds of those living with hypertension are in low- and middle-income countries where most of the world's population lives”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“In high-income countries, the average rates of awareness, treatment, and control are 67%, 55.6%, and 28.4%, respectively, while in low- to middle-income countries the rates are 37.9%, 29%, and 7.7%, respectively.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Self-citationForouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Global burden of blood-pressure-related disease, 2001
Lawes, C. M. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,314
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,006
Pramusita, A., Kitaura, H., Ohori, F., Noguchi, T., Marahleh, A., Nara, Y., Kinjo, R., Ma, J., Kanou, K., Tanaka, Y., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.816764 · Cited by 20
Fernández, L. G., Firima, E., Robinson, E., Ursprung, F., Huber, J., Amstutz, A., Gupta, R., Gerber, F., Mokhohlane, J., Lejone, T. I., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13467-4 · Cited by 18
Lee, S. J., Lee, S., Choi, H., Lee, J., Jeong, Y. W., Kang, D. R., & Sung, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226677 · Cited by 23
Tebelu, D. T., Assefa, T., Getahun, M. S., Negussie, Y. M., & Gurara, A. M. (2023) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-022-00508-x · Cited by 24
Zhao, Y., Feng, Y., Zeng, Y., Di, W., Luo, X., Wu, X., Guan, R., Xu, L., Yang, X., Li, Y., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2213330 · Cited by 20
“Observational studies are graded as low-quality evidence by default and downgraded if they have any of the following criteria (Mills et al. 2016): risk of bias (defined as study quality <6); inconsistency (substantial between studies heterogeneity, I2 > 50%, or PQ <0.10); indirectness (presence of…”
InfluentialBaray, A. H., Stanikzai, M. H., Wafa, M. H., & Akbari, K. (2023) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s417205 · Cited by 20
Huang, K., Yu, D., Fang, H., Ju, L., Piao, W., Guo, Q., Xu, X., Wei, X., Yang, Y., & Zhao, L. (2023) · Environmental Health · doi:10.1186/s12940-023-01000-y · Cited by 20
Park, C. H., Kim, H. W., Joo, Y. S., Park, J. T., Chang, T. I., Yoo, T., Park, S. K., Kim, Y. H., Sung, S. A., Hyun, Y. Y., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.12.008 · Cited by 20
Ahari, R. K., Sahranavard, T., Mansoori, A., Fallahi, Z., Babaeepoor, N., Ferns, G. A., & Ghayour‐Mobarhan, M. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14829 · Cited by 20
Song, J., Zhang, Y., Lin, Z., Tang, J., Yang, X., & Liu, F. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04254-w · Cited by 20
Alcohol intake reduction for controlling hypertension
Acín, T., Rueda, J.-R., Saiz, L. C., Mathias, V. P., Alzueta, N., Solà, I., Garjón, J., & Erviti, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010022.pub2 · Cited by 20
Health literacy and hypertension outcomes in a multi-ethnic population: the HELIUS study
Miranda, R., Meeks, K. A. C., Snijder, M. B., van den Born, B. H., Fransen, M. P., Peters, R. J. G., Stronks, K., & Agyemang, C. O. (2019) · European Journal of Public Health · doi:10.1093/eurpub/ckz174 · Cited by 20
Seo, E., Kang, P., & Seol, G. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.081 · Cited by 20
Stopa, S. R., César, C. L. G., Segri, N. J., Alves, M. C. G. P., Barros, M. B. D. A., & Goldbaum, M. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00198717 · Cited by 20
Schröer, S., Mayer-Berger, W., & Pieper, C. (2019) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2019.02.001 · Cited by 20
Neufcourt, L., Deguen, S., Bayat, S., Paillard, F., Zins, M., & Grimaud, O. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319842229 · Cited by 20
Prevalência, tratamento e controle da hipertensão arterial com método diferenciado de busca ativa
Menezes, T. D. C., Portes, L. A., & de Oliveira, N. C. (2020) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x202028030357 · Cited by 20
Chia, Y. C., Turana, Y., Sukonthasarn, A., Zhang, Y., Shin, J., Cheng, H., Tay, J. C., Tsoi, K. K. F., Siddique, S., Verma, N., et al. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14226 · Cited by 20
Woo, H. G., Chang, Y., Lee, J. S., & Song, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253257 · Cited by 20
Li, Y., Li, H., Xing, W., Li, J., Du, R., Cao, D., Yang, X., Yang, X., Zhong, G., Zhao, Y., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100766rr · Cited by 21
Yu, G., Fu, H., Huang, W., Zhang, N., Deng, D., Li, G., & Lei, H. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy005 · Cited by 20
Exercise hypertension: Link to myocardial fibrosis in athletes?
Halle, M., Esefeld, K., Schindler, M., & Schunkert, H. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319868795 · Cited by 20
Hung, T., Chen, V. C., Chuang, Y.-C., Hsu, Y., Wu, W., Tsai, Y., McIntyre, R. S., & Weng, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-54996-9 · Cited by 21
Grönroos, R., Eggertsen, R., Bernhardsson, S., & Björk, M. P. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.06.009 · Cited by 24
Therapeutic inertia and contributing factors among ambulatory patients with hypertension
Niriayo, Y. L., Girmay, S., Tesfay, N., Gidey, K., & Asgedom, S. W. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04109-1 · Cited by 22
“The prevalence of hypertension has been steadily rising worldwide, particularly in developing nations [1, 5].”
BackgroundInfluentialEvolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective
Whelton, P. K. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.02.019 · Cited by 21
Yuan, S., Yu, H.-J., Liu, M., Tang, B.-W., Zhang, J., Gašević, D., Larsson, S. C., & He, Q.-Q. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.09.004 · Cited by 19
The Accuracy in Measurement of Blood Pressure (AIM‐BP) collaborative: Background and rationale
Padwal, R. S., Campbell, N. R. C., Weber, M. A., Lackland, D. T., Shimbo, D., Zhang, X., Schutte, A. E., Rakotz, M., Wozniak, G. D., Townsend, R. R., et al. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13735 · Cited by 19
Wang, M., Wu, T., Yu, C., Gao, W., Lv, J., Wu, Y., Qin, X., Tang, X., Gao, P., Zhan, S., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035190 · Cited by 19
Farapti, F., Fatimah, A. D., Astutik, E., Hidajah, A. C., & Rochmah, T. N. (2020) · Journal of Nutrition and Metabolism · doi:10.1155/2020/8793869 · Cited by 23
Intensive blood pressure lowering: a practical review
Camafort, M., Redón, J., Pyun, W. B., & Coca, A. (2020) · Clinical Hypertension · doi:10.1186/s40885-020-00153-z · Cited by 19
Jones, E. S. W., Esack, I., Mangena, P., & Rayner, B. L. (2020) · Medicine · doi:10.1097/md.0000000000023137 · Cited by 19
“3 vs in females, respectively.([7]) This high and rising prevalence of hypertension, particularly from low to middle income countries, calls for increased attention to the prevention and management of hypertension in adolescents and young adults.”
BackgroundPillsbury, M. M., Mwangi, E. M., Andesia, J., Njuguna, B., Bloomfield, G. S., Chepchumba, A., Kamano, J. H., Mercer, T., Miheso, J., Pastakia, S. D., et al. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06930-2 · Cited by 19
Hypertension and Atrial Fibrillation: A Study on Epidemiology and Mendelian Randomization Causality
Liao, L., Wen, X.-Y., Zhang, S., Li, W., & Zhuang, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.644405 · Cited by 18
Gupta, R. D., Chakraborty, P. A., & Hossain, M. B. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13625 · Cited by 19
Wehkamp, K., Kiefer, F. B., Geiger, F., Scheibler, F., Rueffer, J. U., Donner‐Banzhoff, N., & Betsch, C. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s311470 · Cited by 19
Khan, J. R., Hossain, M. B., & Gupta, R. D. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15344-w · Cited by 19
Hou, C.-C., Tantoh, D. M., Lin, C.-C., Chen, P.-H., Yang, H., & Liaw, Y. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00605-9 · Cited by 19
Mfinanga, S., Nyirenda, M., Mutungi, G. N., Mghamba, J. M., Maongezi, S., Musinguzi, J., Okebe, J., Kivuyo, S. L., Birungi, J., van Widenfelt, E., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047979 · Cited by 19
Ayogu, R. N. B., Ezeh, M. G., & Okafor, A. M.-A. (2021) · Archives of Public Health · doi:10.1186/s13690-021-00724-y · Cited by 19
Plasma Lipidomic Subclasses and Risk of Hypertension in Middle-Aged and Elderly Chinese
Niu, Z., Wu, Q., Luo, Y., Wang, D., Zheng, H., Wu, Y., Yang, X., Zeng, R., Sun, L. T., & Lin, X. (2022) · Phenomics · doi:10.1007/s43657-022-00057-y · Cited by 19
Zhang, J., Mao, Y., Yansong, L. I., Zhao, K., Xie, Q., Wang, K., & Shi, J. C. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.11.014 · Cited by 19
Skin Sodium and Blood Pressure Regulation
Jhee, J. H., Park, H. C., & Choi, H. Y. (2022) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2022.20.1.1 · Cited by 20
Bista, S., Chatzidiakou, L., Jones, R. L., Benmarhnia, T., Postel‐Vinay, N., & Chaix, B. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115720 · Cited by 19
Yi, Q., Hu, H. Z., & Zeng, Q. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2195996 · Cited by 19
Ding, N., Karvonen-Gutierrez, C. A., Zota, A. R., Mukherjee, B., Harlow, S. D., & Park, S. K. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115813 · Cited by 21
Combined exposure to multiple metals on hypertension in NHANES under four statistical models
Zhao, S.-F., Fan, L., Wang, Y., Dong, S., Han, M., Qin, Y., Chen, J., & Liu, A. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-28902-1 · Cited by 19
Self-citationUeno, K., Kaneko, H., Okada, A., Suzuki, Y., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., Morita, H., et al. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107685 · Cited by 22
Lyon, M., Fullerton, J. L., Kennedy, S., & Work, L. M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108575 · Cited by 22
Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues
Shokoples, B. G., Paradis, P., & Schiffrin, E. L. (2024) · Hypertension Research · doi:10.1038/s41440-024-01731-6 · Cited by 19
Zhang, H., Lin, Y., Li, S., Bi, J., Zeng, J., Mo, C., Xu, S., Jia, B., Lu, Y., Liu, C., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127788 · Cited by 20
Farih, O. A., Ali, A. O., Abokor, A. H., Ali, M. A., Egge, A. A. A., & Muse, A. H. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102783 · Cited by 19
Tracking and Transition Probability of Blood Pressure From Childhood to Midadulthood
Meng, Y., Sharman, J. E., Iiskala, F., Wu, F., Juonala, M., Pahkala, K., Rovio, S., Fraser, B. J., Kelly, R. K., Hutri, N., et al. (2024) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2024.4368 · Cited by 20
β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy
Lai, C., Pandey, S., Day, C. H., Ho, T., Chen, R., Chang, R., Pai, P., Padma, V. V., Kuo, W., & Huang, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174288 · Cited by 19
Wang, L., & Wu, W. (2019) · Food & Function · doi:10.1039/c9fo02127b · Cited by 19
Shim, J., Jung, S. J., & Kim, H. C. (2019) · Clinical Hypertension · doi:10.1186/s40885-019-0130-z · Cited by 19
Cai, R., Wu, X., Li, C., & Chao, J. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002442 · Cited by 20
“1% of the global population [1], and it is a major public health concern worldwide.”
BackgroundBlok, S., van der Linden, E. L., Somsen, G. A., Tulevski, I. I., Winter, M. M., & van den Born, B. H. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320957170 · Cited by 19
Silva, E. A. P., Carvalho, J. S., dos Santos, D. M., Oliveira, A. M. S., Araújo, A. A. D. S., Serafini, M. R., Santos, L., Batista, M. V. D. A., dos Santos, M. R. V., Quintans, J. D. S. S., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174060 · Cited by 23
Du, H., Xiao, G., Xue, Z., Li, Z., He, S., Du, X., Zhou, Z., Cao, L., Wang, Y., Yang, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111941 · Cited by 19
Niu, M., Wang, Y., Zhang, L., Tu, R., Liu, X., Hou, J., Huo, W., Mao, Z., Wang, C., & Bie, R. (2021) · Hypertension Research · doi:10.1038/s41440-021-00738-7 · Cited by 19
Dietary Mineral Intake from Nuts and Its Relationship to Hypertension Among Korean Adults
Bae, Y., Kim, M., & Choi, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02952-3 · Cited by 19
Development of a risk prediction score for hypertension incidence using Japanese health checkup data
Kawasoe, M., Kawasoe, S., Kubozono, T., Ojima, S., Kawabata, T., Ikeda, Y., Oketani, N., Miyahara, H., Tokushige, K., Miyata, M., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00831-x · Cited by 20
Risk Factors for Low Pharmacy Refill Adherence Among Older Hypertensive Men and Women by Race
Williams, L. G., Peacock, E., Joyce, C., Bazzano, L., Sarpong, D. F., Whelton, P. K., Holt, E. W., Ré, R. N., Frohlich, E. D., He, J., et al. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.07.007 · Cited by 19
Self-citationEffect of Overweight and Obesity on High Blood Pressure in Chinese Children and Adolescents
Dong, Y., Jan, C., Zou, Z., Dong, B., Wang, Z., Yang, Z., Li, Y., Wen, B., Ma, Y., Song, Y., et al. (2019) · Obesity · doi:10.1002/oby.22562 · Cited by 20
Wang, N., Rueter, P., Salam, A., Huffman, M. D., Atkins, E., Ojji, D. B., de Silva, A., Webster, R. J., Chow, C. K., Whelton, P. K., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101883 · Cited by 18
Hallberg, I., Ranerup, A., Bengtsson, U., & Kjellgren, K. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s157658 · Cited by 14
Yang, D.-Y. D., Nie, Z., Liao, L., Zhang, S., Zhou, H., Sun, X., Zhong, X., Du, Z., Zhuang, X., & Liao, X. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319856733 · Cited by 18
Santos, L. P., & Umpierre, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00840 · Cited by 20
Low-Dose Combination Therapy for Initial Treatment of Hypertension
Atkins, E., & Chow, C. K. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01069-7 · Cited by 18
Passi‐Solar, Á., Margozzini, P., Mindell, J. S., Ruiz, M. A., Valencia‐Hernández, C. A., & Scholes, S. (2020) · BMC Public Health · doi:10.1186/s12889-020-09483-x · Cited by 18
Jones, M. D., Munir, M., Wilkonski, A., Ng, K., Beynon, G., & Keech, A. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-00421-3 · Cited by 19
Bijani, M., Parvizi, S., Dehghan, A., Rahimabadi, M. S., Chijan, M. R., Kazemi, M., Naghizadeh, M. M., Ghaemi, A., Homayounfar, R., & Farjam, M. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01797-3 · Cited by 18
Kazé, A. D., Musani, S. K., Correa, A., Bertoni, A. G., Golden, S. H., Abdalla, M., & Echouffo-Tcheugui, J. B. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002920 · Cited by 18
Tsuchida-Nishiwaki, M., Uchida, H., Takeuchi, H., Nishiwaki, N., Maeshima, Y., Saito, C., Sugiyama, H., Wada, J., Narita, I., Watanabe, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94467-z · Cited by 18
Blood pressure management and renal protection: Revisiting hypertensive nephropathy
Kao, T., & Huang, C. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000600 · Cited by 20
Wu, H., Wu, J., Zhang, Z., Zheng, Y., Niu, W., Zheng, L., & Li, J. (2021) · Clinical Epidemiology · doi:10.2147/clep.s322791 · Cited by 18
Mebrahtu, G., Moleki, M. M., Achila, O. O., Seyoum, Y., Adgoy, E. T., & Ovberedjo, M. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s319987 · Cited by 23
Hypertension prevalence, awareness, treatment and control in 2019 in the adult population of Mayotte
Calas, L., Subiros, M., Ruello, M., Youssouf, H., Gabet, A., Angue, M., Pointeau, O., Olié, V., & Grave, C. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckac015 · Cited by 18
Teo, Y. H., Chia, A. Z. Q., Teo, Y. N., Chong, E. Y., Syn, N. L. X., Cheong, J. Y. A., Ong, H. T., Wee, C. F., Ting, A. Z. H., Tan, J. T. A., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003280 · Cited by 18
Garcia, R. G., Staley, R., Aroner, S. A., Stowell, J. A., Sclocco, R., Napadow, V., Barbieri, R., & Goldstein, J. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1038339 · Cited by 18
Tan, L., Long, L., Ma, X., Yang, W., Liao, F.-F., Peng, Y., Lu, J., Shen, A.-L., Dong-qing, A., Qu, H., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.941341 · Cited by 22
Wang, Z., Wang, Y., Xiong, J., Gan, X., Bao, Y., Jiang, A., Zhou, Y., Huangfu, Z., Yang, Y., Liu, Z., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1121340 · Cited by 19
The epithelial sodium channel in inflammation and blood pressure modulation
Ahmad, T., Ertuğlu, L. A., Masenga, S. K., Kleyman, T. R., & Kirabo, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1130148 · Cited by 21
Summary of Known Genetic and Epigenetic Modification Contributed to Hypertension
Pratamawati, T. M., Alwi, I., & Asmarinah, A. (2023) · International Journal of Hypertension · doi:10.1155/2023/5872362 · Cited by 18
Asante, D. O., Dai, A., Walker, A. N., Zhou, Z., Kpogo, S. A., Lu, R., Huang, K., & Zou, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1056999 · Cited by 18
Darricarrère, C., Jacquot, E., Bricout, S., Louis, C., Bénard, M., & Poulter, N. R. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14699 · Cited by 18
Cumulative Blood Pressure Load and Incident CKD
Park, H., Park, S., Seong, Y., Kim, H. J., Choi, H. Y., Park, H. C., & Jhee, J. H. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.05.015 · Cited by 18
Rheeder, P., Morris-Paxton, A. A., Ewing, R.-M. G., & Woods, D. (2017) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v9i1.1466 · Cited by 18
South Asians’ experience of managing hypertension: a grounded theory study
King‐Shier, K. M., Dhaliwal, K. K., Puri, R., LeBlanc, P., & Johal, J. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s196224 · Cited by 18
Buie, J. N. J., Hammad, S. M., Nietert, P. J., Magwood, G., Adams, R. J., Bonilha, L., & Sims‐Robinson, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216213 · Cited by 19
Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice
Vorselaars, W. M. C. M., van Beek, D., Postma, E. L., Spiering, W., Rinkes, I. H. M. B., Valk, G. D., Vriens, M. R., International CONNsortium Study Group, Zarnegar, R., Fahey, T. J., et al. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05074-z · Cited by 18
Hernández‐Vásquez, A., Rojas‐Roque, C., Santero, M., Maza, J. C. R., Casas-Bendezú, M., & Miranda, J. J. (2019) · Revista médica de Chile · doi:10.4067/s0034-98872019000500545 · Cited by 17
Zhao, Y., Zhu, J., Liang, H., Yang, S., Zhang, Y., Han, W., Chen, C., Cao, N., Aruhan, Liang, P., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01548 · Cited by 19
Savage, A., Schubert, L., Huber, C., Bambrick, H., Lansbury, N., & Bellotti, B. (2020) · Weather Climate and Society · doi:10.1175/wcas-d-19-0090.1 · Cited by 18
McCallum, L., Brooksbank, K. J. M., McConnachie, A., Aman, A., Lip, S. Z. L., Dawson, J., MacIntyre, I. M., MacDonald, T. M., Webb, D. J., & Padmanabhan, S. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa166 · Cited by 18
Islam, A. F. M., Lambert, É., Islam, S. M. S., Islam, M. A., Biswas, D., McDonald, R. L., Maddison, R., Thompson, B., & Lambert, G. W. (2021) · Trials · doi:10.1186/s13063-021-05379-2 · Cited by 18
Song, R., Mishra, J. S., Dangudubiyyam, S. V., Antony, K. M., Baker, T. L., Watters, J. J., & Kumar, S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00739-4 · Cited by 19
Han, Y., Han, K., Han, X., Yin, Y., Di, H., Wu, J., Zhang, Y., & Zeng, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.755509 · Cited by 18
Liu, Y., Yu, L., Zhu, M., Lin, W., Liu, Y., Li, M., Zhang, Y., Ji, H., & Wang, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.135985 · Cited by 18
Metadata
- Authors
- Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J.
- Affiliations
- Tulane University (US)
- ORCID
- Venue
- Circulation
- Published
- 2016-08-09
- Volume
- 134
- Issue
- 6
- Pages
- 441-450
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC4979614
- OpenAlex
- W2504981678
- Cited by
- 3,531
- References
- 39
- Citations by year
- 2026: 248 · 2025: 362 · 2024: 410 · 2023: 432 · 2022: 468 · 2021: 549 · 2020: 401 · 2019: 331 · 2018: 203 · 2017: 113 · 2016: 10
- FWCI
- 180.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- World Health Organization
- National Heart, Lung, and Blood Institute (U01HL114197, T32HL007024)
- National Institute of General Medical Sciences (P20GM109036)
- Fogarty International Center (D43TW009107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- hypertension, global health disparities, hypertension prevalence, hypertension awareness, antihypertensive therapy, blood pressure control, low- and middle-income countries, high-income countries, secular trends, global burden of disease
- MeSH terms
- Cross-Sectional Studies, Developing Countries, Humans, Hypertension, Population Surveillance, Global Health, Prevalence, Developed Countries, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review